Nerve block shows promise for Alzheimer's memory loss
NCT ID NCT07351773
First seen Jan 20, 2026 · Last updated May 21, 2026 · Updated 20 times
Summary
This study tested whether a nerve block called stellate ganglion block (SGB), given with standard medication, could improve thinking and memory in people with Alzheimer's disease. Forty participants were randomly assigned to receive either SGB plus standard drugs or standard drugs alone. Researchers measured changes in memory, anxiety, mood, and quality of life over six months to see if the nerve block provided extra benefit.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COGNITIVE DYSFUNCTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Taizhou Second People's Hospital
Taizhou, Zhejiang, 317200, China
Conditions
Explore the condition pages connected to this study.